1 / 5

Group A : Angola – Mozambique – RdC –Mauritius - Kenya

Group A : Angola – Mozambique – RdC –Mauritius - Kenya. G roup B : Namibia – Seychelles - South Africa - Uganda. Group C : Botswana - Lesotho – Swaziland -Tanzania. Group D : Nigeria – South Africa – Zambia – ZBWE. Aim.

riva
Download Presentation

Group A : Angola – Mozambique – RdC –Mauritius - Kenya

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Group A: Angola – Mozambique – RdC –Mauritius - Kenya Group B: Namibia – Seychelles - South Africa - Uganda Group C: Botswana - Lesotho – Swaziland -Tanzania Group D: Nigeria – South Africa – Zambia – ZBWE

  2. Aim Goal of each group : develop three to four recommendations for a regional approach on combating counterfeit medical products

  3. Considerations before starting.. Before all, please consider the following angles for discussion within your group: - Legislative principles - Technology / Lab/ Forensic examination - Raising awareness/ communication - Enforcement capacity - Regulatory implementation • Exchange of information / diffusion of alerts • National and international cooperation

  4. Proposed questions to help your discussion: • What are the major barriers to combat counterfeit medicines in your country and in the region? • What is needed for efficient cooperation amongst the agencies within your country? • What is the role of the private sector? • How do you see the role of IMPACT in your national and regional efforts?

  5. How would you build bridges between forensic, health and enforcement? • What are your country and regional needs for analytical tool or kits for rapid testing of suspected products? • Is internet a challenge for your region?

More Related